Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma
Pediatric Dermatology · 2024
DOI: 10.1111/pde.15710 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Leonid Melnikov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Oncology, East Tennessee Children's Hospital, Knoxville, Tennessee, USA. Hauptthemen laut MEDLINE: Pyrimidinones, Pyridones, Neurofibroma, Plexiform, Neurofibromatosis 1. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
An 11‐year‐old female with neurofibromatosis type 1 (NF‐1) and history of optic glioma presented with a progressive cutaneous plexiform neurofibroma of the breast. The lesion was treated with topical application of a mitogen‐activated protein kinase inhibitor, trametinib, resulting in stable, non‐progression cutaneous plexiform neurofibroma for greater than 2 years. This case demonstrates the potential application of topical trametinib for NF1‐associated superficial cutaneous plexiform neurofibroma without the toxicities associated with systemic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology-Oncology, East Tennessee Children's Hospital, Knoxville, Tennessee, USA.
- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Chemistry Rx, Folcroft, Pennsylvania, USA.
ORCID-Profile: Leonid Melnikov, Lars Brichta
Zitieren
APA
Melnikov, L., Brichta, L., & Schloemer, N. J. (2024). Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma. Pediatric Dermatology. https://doi.org/10.1111/pde.15710
Vancouver
Melnikov L, Brichta L, Schloemer NJ. Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma. Pediatric Dermatology. 2024. doi:10.1111/pde.15710
BibTeX
@article{Melnikov2024,
author = {Melnikov, Leonid and Brichta, Lars and Schloemer, Nathan J},
title = {Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma},
journal = {Pediatric Dermatology},
year = {2024},
doi = {10.1111/pde.15710}
}
EUVIMED